ScanSource, Inc. (SCSC) stock

SCSCNasdaqWholesale-Computers & Peripheral Equipment & SoftwareFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3022% below fair value

$44.76+0.50 (+1.12%)

Close on Nov 13, 2026Market cap $901.49MP/E 14.0Yield –

Earnings

ScanSource's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 4, 2027

Q2 FY2027 · estimated, before the open

Revenue, Q1 FY2027

$962.30M

+30.1% on a year earlier

Non-GAAP diluted EPS, Q1 FY2027

$0.86

$1.06 a year earlier

Latest guidance

Issued

Nov 5, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of ScanSource's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q2 FY2027ended Dec 31, 2026	Feb 4, 2027Expected	–	–	–	–	–
Q1 FY2027ended Sep 30, 2026	Nov 5, 2026before the open	$962.30M	+30.1%	$0.42	$0.86	Release
Q4 FY2026ended Jun 30, 2026	Aug 20, 2026before the open	$953.10M	+17.2%	$1.24	$1.46	Release
Q3 FY2026ended Mar 31, 2026	May 7, 2026before the open	$766.80M	+8.8%	$0.78	$0.94	Release
Q2 FY2026ended Dec 31, 2025	Feb 5, 2026before the open	$766.50M	+2.5%	$0.75	$0.80	Release
Q1 FY2026ended Sep 30, 2025	Nov 6, 2025before the open	$739.65M	-4.6%	$0.89	$1.06	Release
Q4 FY2025ended Jun 30, 2025	Aug 21, 2025before the open	$812.90M	+9.0%	$0.88	$1.02	Release
Q3 FY2025ended Mar 31, 2025	May 8, 2025before the open	$704.85M	-6.3%	$0.74	$0.86	Release
Q2 FY2025ended Dec 31, 2024	Jan 30, 2025before the open	$747.50M	-15.5%	$0.70	$0.85	Release
Q1 FY2025ended Sep 30, 2024	Nov 7, 2024before the open	$775.60M	-11.5%	$0.69	$0.84	Release
Q4 FY2024ended Jun 30, 2024	Aug 27, 2024before the open	$746.10M	-21.2%	$0.64	$0.80	Release
Q3 FY2024ended Mar 31, 2024	May 7, 2024before the open	$752.60M	-15.0%	$0.50	$0.69	Release
Q2 FY2024ended Dec 31, 2023	Feb 6, 2024before the open	$884.80M	-12.5%	$1.29	$0.85	Release
Q1 FY2024ended Sep 30, 2023	Nov 9, 2023before the open	$876.30M	-7.2%	$0.61	–	Release
Q4 FY2023ended Jun 30, 2023	Aug 22, 2023before the open	$947.10M	-1.6%	$0.68	–	Release
Q3 FY2023ended Mar 31, 2023	May 9, 2023before the open	$885.50M	+4.7%	$0.83	$0.96	Release
Q2 FY2023ended Dec 31, 2022	Feb 7, 2023before the open	$1.01B	+17.0%	$1.01	$1.06	Release
Q1 FY2023ended Sep 30, 2022	Nov 8, 2022before the open	$943.80M	+10.1%	$0.94	$1.07	Release
Q4 FY2022ended Jun 30, 2022	Aug 23, 2022after the close	$962.30M	–	$0.78	$0.91	Release
Q3 FY2022ended Mar 31, 2022	May 10, 2022after the close	$846.00M	–	$0.91	$1.04	Release
Q2 FY2022ended Dec 31, 2021	Feb 8, 2022after the close	$864.40M	–	$0.89	$1.02	Release
Q1 FY2022ended Sep 30, 2021	Nov 9, 2021after the close	$857.30M	–	$0.86	$0.99	Release
Q4 FY2021ended Jun 30, 2021	Aug 24, 2021after the close	–	–	–	–	Filing
Q3 FY2021ended Mar 31, 2021	May 10, 2021after the close	–	–	–	–	Filing
Q2 FY2021ended Dec 31, 2020	Feb 2, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Sep 30, 2020	Nov 9, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

ScanSource's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Net salesGAAP	FY2027	$3.80B – $4.00B	–	New	Nov 5, 2026
Net sales growth, Y/Y	FY2027	+6% – +10%	–	New	Aug 20, 2026
Adjusted EBITDAnon-GAAP	FY2027	$175.00M – $185.00M	–	New	Nov 5, 2026
Adjusted EBITDA (non-GAAP)non-GAAP	FY2027	$158.00M – $165.00M	–	New	Aug 20, 2026
Free cash flownon-GAAP	FY2027	$85.00M	–	New	Nov 5, 2026
Free cash flow (non-GAAP)non-GAAP	FY2027	$85.00M	–	New	Aug 20, 2026

Guidance vs results

The last range ScanSource gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2026	Revenue	$3.00B – $3.10B	$3.23BΣ4Q	Above range
FY2025	Revenue	$3.00B	$3.04BΣ4Q	Above range

Guidance history

Every forecast ScanSource put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 5, 2026	Adjusted EBITDA	FY2027	$175.00M – $185.00M	New
Nov 5, 2026	Free cash flow	FY2027	$85.00M	New
Nov 5, 2026	Net sales	FY2027	$3.80B – $4.00B	New
Aug 20, 2026	Adjusted EBITDA (non-GAAP)	FY2027	$158.00M – $165.00M	New
Aug 20, 2026	Free cash flow (non-GAAP)	FY2027	$85.00M	New
Aug 20, 2026	Net sales growth, Y/Y	FY2027	+6% – +10%	New
May 7, 2026	Adjusted EBITDA (non-GAAP)	FY2026	$140.00M – $150.00M	Reaffirmed
May 7, 2026	Free cash flow (non-GAAP)	FY2026	$90.00M	Raised
May 7, 2026	Net sales	FY2026	$3.00B – $3.10B	New
Feb 5, 2026	Adjusted EBITDA (non-GAAP)	FY2026	$140.00M – $150.00M	Lowered
Feb 5, 2026	Free cash flow (non-GAAP)	FY2026	$80.00M	Reaffirmed
Feb 5, 2026	Net sales	FY2026	$3.00B – $3.10B	Lowered
Nov 6, 2025	Adjusted EBITDA (non-GAAP)	FY2026	$150.00M – $160.00M	Reaffirmed
Nov 6, 2025	Free cash flow (non-GAAP)	FY2026	$80.00M	Reaffirmed
Nov 6, 2025	Net sales	FY2026	$3.10B – $3.30B	Reaffirmed
Aug 21, 2025	Adjusted EBITDA (non-GAAP)	FY2026	$150.00M – $160.00M	New
Aug 21, 2025	Free cash flow (non-GAAP)	FY2026	$80.00M	New
Aug 21, 2025	Net sales	FY2026	$3.10B – $3.30B	New
May 8, 2025	Adjusted EBITDA (non-GAAP)	FY2025	$140.00M – $145.00M	New
May 8, 2025	Free cash flow (non-GAAP)	FY2025	$70.00M	New
May 8, 2025	Net sales	FY2025	$3.00B	New
Jan 30, 2025	Adjusted EBITDA (non-GAAP)	FY2025	$140.00M – $160.00M	Reaffirmed
Jan 30, 2025	Free cash flow (non-GAAP)	FY2025	$70.00M	Reaffirmed
Jan 30, 2025	Net sales	FY2025	$3.10B – $3.50B	Reaffirmed
Nov 7, 2024	Adjusted EBITDA (non-GAAP)	FY2025	$140.00M – $160.00M	Reaffirmed
Nov 7, 2024	Free cash flow (non-GAAP)	FY2025	$70.00M	Reaffirmed
Nov 7, 2024	Net sales	FY2025	$3.10B – $3.50B	New
Aug 27, 2024	Adjusted EBITDA (non-GAAP)	FY2025	$140.00M – $160.00M	New
Aug 27, 2024	Free cash flow (non-GAAP)	FY2025	$70.00M	New
Aug 27, 2024	Net sales	FY2025	$3.10B – $3.50B	New
May 7, 2024	Capital expenditures	FY2024	$10.00M	Reaffirmed
May 7, 2024	Adjusted EBITDA (non-GAAP)	FY2024	$140.00M	Lowered
May 7, 2024	Free cash flow (non-GAAP)	FY2024	$275.00M	Raised
May 7, 2024	GAAP operating income	FY2024	$96.00M	Lowered
May 7, 2024	GAAP operating cash flow	FY2024	$285.00M	Raised
May 7, 2024	Net sales	FY2024	$3.30B	New
Feb 6, 2024	Capital expenditures	FY2024	$10.00M	Reaffirmed
Feb 6, 2024	Adjusted EBITDA (Non-GAAP)	FY2024	$155.00M	Lowered
Feb 6, 2024	Free cash flow	FY2024	$200.00M	Reaffirmed
Feb 6, 2024	GAAP operating income	FY2024	$111.00M	Lowered
Feb 6, 2024	GAAP operating cash flow	FY2024	$210.00M	Reaffirmed
Feb 6, 2024	Net sales	FY2024	$3.50B	Lowered
Nov 9, 2023	Capital expenditures	FY2024	$10.00M	New
Nov 9, 2023	Adjusted EBITDA (Non-GAAP)	FY2024	$170.00M	New
Nov 9, 2023	Free cash flow	FY2024	$200.00M	New
Nov 9, 2023	GAAP operating income	FY2024	$126.00M	New
Nov 9, 2023	GAAP operating cash flow	FY2024	$210.00M	New
Nov 9, 2023	Net sales	FY2024	$3.80B	New
May 9, 2023	Adjusted EBITDA (non-GAAP)	FY2023	$182.00M	Raised
May 9, 2023	GAAP, Operating income	FY2023	$140.00M	Raised
May 9, 2023	Net sales growth, year-over-year	FY2023	+6.5%	Reaffirmed
Feb 7, 2023	Adjusted EBITDA (non-GAAP)	FY2023	$176.00M	Raised
Feb 7, 2023	GAAP, Operating income	FY2023	$135.00M	Raised
Feb 7, 2023	Net sales growth, year-over-year	FY2023	+6.5%	Raised
Nov 8, 2022	Adjusted EBITDA (non-GAAP)	FY2023	$174.00M	Reaffirmed
Nov 8, 2022	GAAP, Operating income	FY2023	$132.00M	Reaffirmed
Nov 8, 2022	Net sales growth, year-over-year	FY2023	+5.5%	Reaffirmed
Aug 23, 2022	Adjusted EBITDA (non-GAAP)	FY2023	$174.00M	New
Aug 23, 2022	GAAP, Operating income	FY2023	$132.00M	New
Aug 23, 2022	Net sales growth, year-over-year	FY2023	+5.5%	New
May 10, 2022	Adjusted EBITDA (non-GAAP)	FY2022	$165.00M	Raised
May 10, 2022	GAAP, Operating income	FY2022	$122.00M	Raised
May 10, 2022	Net sales growth, year-over-year	FY2022	+10%	Raised
Feb 8, 2022	Adjusted EBITDA (non-GAAP)	FY2022	$148.00M	Raised
Feb 8, 2022	GAAP, Operating income	FY2022	$105.00M	Raised
Feb 8, 2022	Intangible amortization	FY2022	$18.00M	New
Feb 8, 2022	Depreciation expense	FY2022	$13.00M	Lowered
Feb 8, 2022	Share-based compensation expense	FY2022	$12.00M	Lowered
Feb 8, 2022	Net sales growth, year-over-year	FY2022	+7%	Raised
Nov 9, 2021	Adjusted EBITDA (non-GAAP)	FY2022	$135.00M	New
Nov 9, 2021	GAAP, Operating Income	FY2022	$92.00M	New
Nov 9, 2021	Net sales growth, year-over-year	FY2022	+5.5%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.